Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined sirolimus and nintedanib therapy for vascular lesions and hereditary hemorrhagic telangiectasia

Combined sirolimus and nintedanib therapy for vascular lesions and hereditary hemorrhagic telangiectasia

US Patent 12239636 · Granted Mar 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of screening compounds using CALHM (FAM26C)2013
Peptides derived from cadherin and methods of use thereof2011